A scoping review of influenza RdRp-targeting inhibitors: mechanisms, clinical translation, and emerging challenges. [PDF]
Chen Y +6 more
europepmc +1 more source
Identification of (20R)-protopanaxadiol from Panax ginseng as a novel anti-SARS-CoV-2 compound. [PDF]
Takeda M +4 more
europepmc +1 more source
A 56-Year-Old Male Farmer From China With Severe Fever With Thrombocytopenia Syndrome and Pulmonary Aspergillosis: A Case Report and Review of Literature. [PDF]
Lai X, Gao Q, Wu L.
europepmc +1 more source
Retrospective Drug Utilization Pattern of the Use of Antivirals and Its Outcome in Hospitalized COVID-19 Patients in a Tertiary Care Hospital in Mumbai From July to October 2020. [PDF]
Marolia KR, Nerurkar RP.
europepmc +1 more source
SARS-CoV-2 Error Catastrophe Under Molnupiravir: Mutagenic Enhancement Enables Viral Persistence with Impaired Fitness. [PDF]
Tomita Y +3 more
europepmc +1 more source
A sensitive, aqueous-based spectrofluorimetric approach for the determination of favipiravir in presence of its acid-induced degradation product. [PDF]
El-Fattah MHA +3 more
europepmc +1 more source
Predictive modeling of influenza strain drugs using temperature-based topological indices and regression analysis via multi-criteria decision making techniques. [PDF]
Hayat H +3 more
europepmc +1 more source
Andes virus and sin nombre virus: Similarities and distinctive features. [PDF]
Chiappelli F.
europepmc +1 more source
Lassa Virus-A Persistent and Evolving Threat. [PDF]
Hu M, Mantlo E, Huang C.
europepmc +1 more source
Favipiravir treatment in Thai children with COVID-19: effectiveness, safety, and modeling drug exposure. [PDF]
Chaisavaneeyakorn S +19 more
europepmc +1 more source

